New Federal Focus on Fraud, Waste and Abuse May Signal Changes for the Health Care Industry

Why It Matters

Heightened federal scrutiny threatens significant funding losses for states and providers, forcing rapid compliance upgrades and reshaping risk management in the health‑care sector.

Key Takeaways

• CMS placed $259.5M Medicaid fund hold on Minnesota over integrity concerns.
• Federal task force expands fraud enforcement across Medicare, Medicaid, DMEPOS sectors.
• CRUSH RFI seeks rule changes on provider enrollment, AI oversight, lab testing.
• States risk fund deferrals if program integrity improvements lag.
• Six‑month DMEPOS enrollment moratorium tightens equipment supplier controls.

Pulse Analysis

The current administration’s anti‑fraud agenda marks a decisive shift from reactive investigations to proactive, system‑wide enforcement. By establishing an interagency task force, the government is consolidating data analytics, audit authority, and prosecutorial resources to target high‑risk providers across Medicare, Medicaid, and the DMEPOS market. This coordinated approach amplifies the risk of audits, payment suspensions, and criminal charges, compelling health‑care entities to reassess internal controls, billing practices, and third‑party relationships before regulators intervene.

State governments are now on the front lines of this crackdown. CMS’s decision to withhold $259.5 million in Medicaid matching funds from Minnesota—and the threat of a $1 billion deferral—illustrates the tangible financial penalties for inadequate program‑integrity safeguards. Similar pressure is evident in letters dispatched to governors in ten states, urging detailed fraud‑prevention strategies. The six‑month DMEPOS enrollment moratorium further restricts supplier access, prompting providers to tighten enrollment verification and documentation. For health‑care organizations, the immediate priority is to conduct gap analyses, bolster compliance teams, and engage with state agencies to avoid funding disruptions.

The CRUSH Request for Information (RFI) expands the policy conversation, inviting comments on everything from enhanced identity proofing and AI‑driven coding oversight to stricter preclusion lists for Medicare Advantage. While the RFI itself does not impose new rules, the volume of stakeholder feedback signals forthcoming rulemaking that could reshape provider enrollment criteria, laboratory test reimbursement, and surety bond requirements. Companies that proactively adapt—by integrating advanced analytics, improving ownership transparency, and aligning with emerging federal standards—will be better positioned to navigate the evolving regulatory landscape and protect revenue streams.